Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. (HYEX) drives innovation in plant-based nutraceuticals through patented formulations and multi-channel distribution. This dedicated news hub provides investors with verified updates on corporate developments, financial milestones, and market strategies.
Find timely reports on earnings announcements, product launches, intellectual property advancements, and strategic partnerships. Our curated collection simplifies tracking the company’s progress in heart health supplements, cognitive support products, and subscription-based wellness solutions.
Stay informed about HYEX’s operational expansions and regulatory milestones through primary-source press releases. Bookmark this page for direct access to the company’s latest developments in the $400B+ global nutraceutical market.
Healthy Extracts (OTCQB:HYEX) has launched STAT10™, a breakthrough CoQ10 formulation designed specifically for the 40 million Americans using statins. The product addresses nutrient depletion caused by statin medications, targeting common side effects like muscle pain, weakness, and fatigue.
STAT10™ combines six specialized ingredients including Unbiquinone, Omega-3s, Berberine, Bergamot BPF Gold®, Resveratrol, and Vitamin C. Priced at $69.95 for a month's supply, the product is endorsed by Dr. Joel Kahn, a triple board-certified Interventional Cardiologist. The company plans to distribute through multiple channels including direct-to-consumer, social media, affiliate partnerships, and healthcare providers.
Healthy Extracts (OTCQB:HYEX) anticipates record Q1 2025 results with net revenue exceeding $925,000, up 34% year-over-year and 19% sequentially. The company has revised its 2025 revenue outlook upward to $4.2 million from $4.0 million, projecting 34% growth over 2024.
Direct-to-consumer subscription customers increased 83% while Amazon Subscribe & Save customers grew 81% compared to Q1 2024. The company maintained its top three Amazon ranking in its category.
Healthy Extracts plans to launch several new products in 2025, including:
- A heart health formulation for statin users
- MYNUS sugar blocker gel-packs
- Hydrate EZ gel-packs for hydration and focus
- WHITNEY JOHNS™ NUTRITION gut health gel-packs
- COLLAGEN anti-aging gel-packs
Healthy Extracts (OTCQB:HYEX) reported strong financial results for 2024, with net revenue increasing 25% to $3.1 million. The company achieved its first-ever positive Adjusted EBITDA of $61,000 ($0.02 per share) and generated positive operating cash flow of $282,000.
Key financial metrics include:
- Gross profit up 18% to $1.9 million (61.4% margin)
- Operating expenses decreased 46% to $2.1 million
- Net loss reduced to $841,000 ($(0.28) per share)
Operational highlights include a 72% increase in direct-to-consumer subscription customers and 77% growth in Amazon Subscribe & Save customers. The company achieved record Amazon sales, ranking in the top three of its category. For 2025, HYEX projects revenue growth of 29%+ to over $4.0 million, driven by new product launches including sugar blockers, hydration solutions, and heart health formulations.
Healthy Extracts (OTCQB:HYEX) expects to report record results for 2024, with net revenue projected to exceed $3.1 million, up 24% year-over-year. The company achieved positive operating cash flow, driven by an 80% growth in subscription-based recurring revenue through its 'Subscribe & Save' program.
The company maintained a top-three ranking in its Amazon category, demonstrating strong performance in direct-to-consumer channels and momentum with retail partners. For 2025, HYEX plans to launch new products in Q1, including an on-the-go hydration product, a sugar blocker, and a heart health formulation targeting 40 million statin users in the U.S.
The company enters 2025 with solid cash flow, manageable debt, and a favorable capitalization structure, anticipating another year of record growth supported by M&A opportunities.
Healthy Extracts (HYEX) reported record Q3 2024 results with net revenue increasing 21% year-over-year to $745,000. The company achieved a 22% increase in gross profit to $602,000, with gross margin improving to 80.9%. Net income reached $355,000 or $0.12 per share, compared to a loss in the previous year. Subscription-based sales showed strong growth, with Amazon 'Subscribe & Save' customers up 63% and direct-to-consumer subscriptions up 97% year-over-year. The company maintains its guidance for 20%+ revenue growth in 2024, expecting to exceed $3 million with positive cash flow.
Healthy Extracts Inc. (OTCQB:HYEX) anticipates record third quarter 2024 results, with net revenue expected to exceed $740,000, up over 20% year-over-year. The company projects a gross margin exceeding 80%, driving positive operating cash flow and net profitability. Healthy Extracts achieved record sales on Amazon in July, ranking as a top three seller of Citrus Bergamot among more than 100 competitors. The company replaced its traditional buy-2-get-1 offers with a 20% discount for monthly subscription shipments, aiming to increase sales, margins, and customer lifetime value. Healthy Extracts anticipates continued growth in top-line revenue, profitability, and market share expansion, driven by planned new product launches in Q4 2024.
Healthy Extracts (OTCQB:HYEX) announced preliminary results for Q2 2024, projecting record net revenue exceeding $900,000, marking a 30% increase from the previous quarter and over 50% compared to Q2 2023. The company also expects a gross margin above 53%, leading to positive operating cash flow and its third consecutive quarter of net profitability, excluding non-core and non-cash expenses. The growth is attributed to substantial direct-to-consumer and wholesale revenue. Additionally, Healthy Extracts paid down more than $100,000 in debt and improved its cash position, forecasting a third cash flow-positive quarter with over $140,000. The company aims to leverage its market channels to launch new products and expand revenue streams throughout the year, enhancing shareholder value.